PDF herunterladen
Thromb Haemost 2019; 119(10): 1563-1572
DOI: 10.1055/s-0039-1693702
Theme Issue Article
Georg Thieme Verlag KG Stuttgart · New York

MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease

Stefan Stojkovic
1   University Clinic for Internal Medicine II, Department of Cardiology, Medical University of Vienna, Vienna, Austria
,
Anne Yaël Nossent
1   University Clinic for Internal Medicine II, Department of Cardiology, Medical University of Vienna, Vienna, Austria
,
Paul Haller
2   3rd Department of Internal Medicine, Cardiology, Intensive Care Medicine and Chest Pain Unit, Wilhelminenhospital, Vienna, Austria
,
Bernhard Jäger
2   3rd Department of Internal Medicine, Cardiology, Intensive Care Medicine and Chest Pain Unit, Wilhelminenhospital, Vienna, Austria
3   Medical Faculty, Sigmund Freud University, Vienna, Austria
,
Kris G. Vargas
2   3rd Department of Internal Medicine, Cardiology, Intensive Care Medicine and Chest Pain Unit, Wilhelminenhospital, Vienna, Austria
,
Johann Wojta
1   University Clinic for Internal Medicine II, Department of Cardiology, Medical University of Vienna, Vienna, Austria
4   Core Facilities, Medical University of Vienna, Vienna, Austria
5   Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna Austria
,
Kurt Huber
2   3rd Department of Internal Medicine, Cardiology, Intensive Care Medicine and Chest Pain Unit, Wilhelminenhospital, Vienna, Austria
3   Medical Faculty, Sigmund Freud University, Vienna, Austria
› Institutsangaben
Weitere Informationen

Publikationsverlauf

11. März 2019

12. Juni 2019

Publikationsdatum:
17. August 2019 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Erratum zu diesem Artikel:

ErratumThromb Haemost 2019; 119(10): e1-e1
DOI: 10.1055/s-0040-1702204

Abstract

Microribonucleic acids (miRs) are small, noncoding ribonucleic acids (RNAs), which play an important role in the regulation of platelet function and activity. Several studies proposed a mechanistic role of platelet-related miRs in the pathophysiology of coronary artery disease (CAD) and atherothrombosis. Circulating, platelet-related miRs have been proposed as diagnostic, prognostic, as well as treatment response biomarkers in CAD and acute coronary syndrome (ACS). In this review, we summarize recent studies on the role of platelet-related miRs in the regulation of platelet function and activity. Furthermore, we review the studies investigating the role of platelet-related miRs as biomarkers in patients with CAD and ACS.

Keywords

microRNA - platelet function - coronary artery disease - acute myocardial infarction - acute coronary syndrome
 

  • References

  • 1 Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455 (7209): 64-71
    CrossrefPubMedGoogle Scholar
  • 2 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136 (02) 215-233
    CrossrefPubMedGoogle Scholar
  • 3 Mitchell PS, Parkin RK, Kroh EM. , et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105 (30) 10513-10518
    CrossrefPubMedGoogle Scholar
  • 4 Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9 (06) 654-659
    CrossrefPubMedGoogle Scholar
  • 5 Hunter MP, Ismail N, Zhang X. , et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3 (11) e3694
    CrossrefPubMedGoogle Scholar
  • 6 Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13 (04) 423-433
    CrossrefPubMedGoogle Scholar
  • 7 Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39 (16) 7223-7233
    CrossrefPubMedGoogle Scholar
  • 8 Wang GK, Zhu JQ, Zhang JT. , et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31 (06) 659-666
    CrossrefPubMedGoogle Scholar
  • 9 D'Alessandra Y, Devanna P, Limana F. , et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010; 31 (22) 2765-2773
    CrossrefPubMedGoogle Scholar
  • 10 Fichtlscherer S, De Rosa S, Fox H. , et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107 (05) 677-684
    CrossrefPubMedGoogle Scholar
  • 11 Tijsen AJ, Creemers EE, Moerland PD. , et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res 2010; 106 (06) 1035-1039
    CrossrefPubMedGoogle Scholar
  • 12 Zampetaki A, Kiechl S, Drozdov I. , et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010; 107 (06) 810-817
    CrossrefPubMedGoogle Scholar
  • 13 Stojkovic S, Jurisic M, Kopp CW. , et al. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Atherosclerosis 2018; 269: 197-203
    CrossrefPubMedGoogle Scholar
  • 14 Ahlin F, Arfvidsson J, Vargas KG, Stojkovic S, Huber K, Wojta J. MicroRNAs as circulating biomarkers in acute coronary syndromes: a review. Vascul Pharmacol 2016; 81: 15-21
    CrossrefPubMedGoogle Scholar
  • 15 Hohensinner PJ, Kaun C, Ebenbauer B. , et al. Reduction of premature aging markers after gastric bypass surgery in morbidly obese patients. Obes Surg 2018; 28 (09) 2804-2810
    CrossrefPubMedGoogle Scholar
  • 16 Merkerova M, Belickova M, Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 2008; 81 (04) 304-310
    CrossrefPubMedGoogle Scholar
  • 17 Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009; 16 (09) 961-966
    CrossrefPubMedGoogle Scholar
  • 18 Rowley JW, Chappaz S, Corduan A. , et al. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. Blood 2016; 127 (14) 1743-1751
    CrossrefPubMedGoogle Scholar
  • 19 Nagalla S, Shaw C, Kong X. , et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011; 117 (19) 5189-5197
    CrossrefPubMedGoogle Scholar
  • 20 Osman A, Fälker K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011; 22 (06) 433-441
    CrossrefPubMedGoogle Scholar
  • 21 Stratz C, Nührenberg TG, Binder H. , et al. Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNA. Thromb Haemost 2012; 107 (04) 634-641
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 22 Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One 2012; 7 (12) e50746
    CrossrefPubMedGoogle Scholar
  • 23 Simon LM, Edelstein LC, Nagalla S. , et al. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 2014; 123 (16) e37-e45
    CrossrefPubMedGoogle Scholar
  • 24 Edelstein LC, Simon LM, Montoya RT. , et al. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med 2013; 19 (12) 1609-1616
    CrossrefPubMedGoogle Scholar
  • 25 Nassa G, Giurato G, Cimmino G. , et al. Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. Sci Rep 2018; 8 (01) 498
    CrossrefPubMedGoogle Scholar
  • 26 Elgheznawy A, Shi L, Hu J. , et al. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. Circ Res 2015; 117 (02) 157-165
    CrossrefPubMedGoogle Scholar
  • 27 Leierseder S, Petzold T, Zhang L, Loyer X, Massberg S, Engelhardt S. MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost 2013; 110 (06) 1207-1214
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 28 Welten SM, Goossens EA, Quax PH, Nossent AY. The multifactorial nature of microRNAs in vascular remodelling. Cardiovasc Res 2016; 110 (01) 6-22
    CrossrefPubMedGoogle Scholar
  • 29 Luo M, Li R, Ren M. , et al. Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets. Sci Rep 2016; 6: 36687
    CrossrefPubMedGoogle Scholar
  • 30 Fejes Z, Póliska S, Czimmerer Z. , et al. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. Thromb Haemost 2017; 117 (03) 529-542
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 31 Garcia A, Dunoyer-Geindre S, Zapilko V, Nolli S, Reny JL, Fontana P. Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells. Thromb Haemost 2019; 119 (02) 254-263
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 32 Kaudewitz D, Skroblin P, Bender LH. , et al. Association of microRNAs and YRNAs with platelet function. Circ Res 2016; 118 (03) 420-432
    CrossrefPubMedGoogle Scholar
  • 33 Kondkar AA, Bray MS, Leal SM. , et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 2010; 8 (02) 369-378
    CrossrefPubMedGoogle Scholar
  • 34 Zhou Y, Abraham S, Andre P. , et al. Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice. Blood 2015; 126 (26) 2871-2881
    PubMedGoogle Scholar
  • 35 Miao X, Rahman MF, Jiang L. , et al. Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1. J Thromb Haemost 2018; 16 (04) 791-801
    CrossrefPubMedGoogle Scholar
  • 36 Thum T, Gross C, Fiedler J. , et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456 (7224): 980-984
    PubMedGoogle Scholar
  • 37 Barwari T, Eminaga S, Mayr U. , et al. Inhibition of profibrotic microRNA-21 affects platelets and their releasate. JCI Insight 2018; 3 (21) 3
    PubMedGoogle Scholar
  • 38 Ambrose AR, Alsahli MA, Kurmani SA, Goodall AH. Comparison of the release of microRNAs and extracellular vesicles from platelets in response to different agonists. Platelets 2018; 29 (05) 446-454
    CrossrefPubMedGoogle Scholar
  • 39 Gidlöf O, van der Brug M, Ohman J. , et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood 2013; 121 (19) 3908-3917
    CrossrefPubMedGoogle Scholar
  • 40 Laffont B, Corduan A, Plé H. , et al. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 2013; 122 (02) 253-261
    PubMedGoogle Scholar
  • 41 Pan Y, Liang H, Liu H. , et al. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol 2014; 192 (01) 437-446
    CrossrefPubMedGoogle Scholar
  • 42 Li J, Tan M, Xiang Q, Zhou Z, Yan H. Thrombin-activated platelet-derived exosomes regulate endothelial cell expression of ICAM-1 via microRNA-223 during the thrombosis-inflammation response. Thromb Res 2017; 154: 96-105
    CrossrefPubMedGoogle Scholar
  • 43 Zhang Y, Zhang W, Zha C, Liu Y. Platelets activated by the anti-β2GPI/β2GPI complex release microRNAs to inhibit migration and tube formation of human umbilical vein endothelial cells. Cell Mol Biol Lett 2018; 23: 24
    CrossrefPubMedGoogle Scholar
  • 44 Tan M, Yan HB, Li JN. , et al. Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Cell Physiol Biochem 2016; 38 (06) 2348-2365
    CrossrefPubMedGoogle Scholar
  • 45 Yang Y, Luo H, Liu S. , et al. Platelet microparticles-containing miR-4306 inhibits human monocyte-derived macrophages migration through VEGFA/ERK1/2/NF-κB signaling pathways. Clin Exp Hypertens 2019; 41 (05) 481-491
    CrossrefPubMedGoogle Scholar
  • 46 Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012; 119 (26) 6288-6295
    CrossrefPubMedGoogle Scholar
  • 47 Flierl U, Nero TL, Lim B. , et al. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators. J Exp Med 2015; 212 (02) 129-137
    CrossrefPubMedGoogle Scholar
  • 48 Sondermeijer BM, Bakker A, Halliani A. , et al. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One 2011; 6 (10) e25946
    CrossrefPubMedGoogle Scholar
  • 49 Willeit P, Zampetaki A, Dudek K. , et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 2013; 112 (04) 595-600
    CrossrefPubMedGoogle Scholar
  • 50 de Boer HC, van Solingen C, Prins J. , et al. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J 2013; 34 (44) 3451-3457
    CrossrefPubMedGoogle Scholar
  • 51 Shi R, Ge L, Zhou X. , et al. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res 2013; 131 (06) 508-513
    CrossrefPubMedGoogle Scholar
  • 52 Zhang YY, Zhou X, Ji WJ. , et al. Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. J Thromb Thrombolysis 2014; 38 (01) 65-72
    CrossrefPubMedGoogle Scholar
  • 53 Chyrchel B, Totoń-Żurańska J, Kruszelnicka O. , et al. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: a preliminary report. Platelets 2015; 26 (06) 593-597
    CrossrefPubMedGoogle Scholar
  • 54 Peng L, Liu J, Qin L. , et al. Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS. Thromb Res 2017; 157: 97-102
    CrossrefPubMedGoogle Scholar
  • 55 Binderup HG, Houlind K, Madsen JS, Brasen CL. Aspirin resistance may be identified by miR-92a in plasma combined with platelet distribution width. Clin Biochem 2016; 49 (15) 1167-1172
    CrossrefPubMedGoogle Scholar
  • 56 Chen S, Qi X, Chen H. , et al. Expression of miRNA-26a in platelets is associated with clopidogrel resistance following coronary stenting. Exp Ther Med 2016; 12 (01) 518-524
    CrossrefPubMedGoogle Scholar
  • 57 Chen YC, Lin FY, Lin YW. , et al. Platelet microRNA 365-3p expression correlates with high on-treatment platelet reactivity in coronary artery disease patients. Cardiovasc Drugs Ther 2019; 33 (02) 129-137
    CrossrefPubMedGoogle Scholar
  • 58 Carino A, De Rosa S, Sorrentino S. , et al. Modulation of circulating microRNAs levels during the switch from clopidogrel to ticagrelor. BioMed Res Int 2016; 2016: 3968206
    PubMedGoogle Scholar
  • 59 La Rosa G, Biasucci LM, Mandolini C. , et al. Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment. J Cardiovasc Med (Hagerstown) 2018; 19 (10) 611-613
    CrossrefPubMedGoogle Scholar
  • 60 Massimi I, Lotti LV, Temperilli F. , et al. Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment. Thromb Haemost 2016; 116 (06) 1100-1110
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 61 Sun X, Zhang M, Sanagawa A. , et al. Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol. Thromb J 2012; 10 (01) 16
    CrossrefPubMedGoogle Scholar
  • 62 Long G, Wang F, Duan Q. , et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 2012; 8 (06) 811-818
    CrossrefPubMedGoogle Scholar
  • 63 Wang KJ, Zhao X, Liu YZ. , et al. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem 2016; 38 (03) 1015-1029
    CrossrefPubMedGoogle Scholar
  • 64 Zile MR, Mehurg SM, Arroyo JE, Stroud RE, DeSantis SM, Spinale FG. Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction. Circ Cardiovasc Genet 2011; 4 (06) 614-619
    CrossrefPubMedGoogle Scholar
  • 65 Li C, Fang Z, Jiang T. , et al. Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC Med Genomics 2013; 6: 16
    CrossrefPubMedGoogle Scholar
  • 66 Corsten MF, Dennert R, Jochems S. , et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010; 3 (06) 499-506
    CrossrefPubMedGoogle Scholar
  • 67 Coskunpinar E, Cakmak HA, Kalkan AK, Tiryakioglu NO, Erturk M, Ongen Z. Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarction. Gene 2016; 591 (01) 90-96
    CrossrefPubMedGoogle Scholar
  • 68 Oerlemans MI, Mosterd A, Dekker MS. , et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 2012; 4 (11) 1176-1185
    CrossrefPubMedGoogle Scholar
  • 69 Darabi F, Aghaei M, Movahedian A, Pourmoghadas A, Sarrafzadegan N. The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome. Mol Cell Biochem 2016; 422 (1-2): 51-60
    CrossrefPubMedGoogle Scholar
  • 70 Olivieri F, Antonicelli R, Lorenzi M. , et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 2013; 167 (02) 531-536
    CrossrefPubMedGoogle Scholar
  • 71 Wang F, Long G, Zhao C. , et al. Atherosclerosis-related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction. PLoS One 2014; 9 (09) e105734
    CrossrefPubMedGoogle Scholar
  • 72 Ward JA, Esa N, Pidikiti R. , et al. Circulating cell and plasma microRNA profiles differ between non-ST-segment and ST-segment-elevation myocardial infarction. Fam Med Med Sci Res 2013; 2 (02) 108
    PubMedGoogle Scholar
  • 73 Li S, Guo LZ, Kim MH, Han JY, Serebruany V. Platelet microRNA for predicting acute myocardial infarction. J Thromb Thrombolysis 2017; 44 (04) 556-564
    CrossrefPubMedGoogle Scholar
  • 74 Parahuleva MS, Euler G, Mardini A. , et al. Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study. Sci Rep 2017; 7 (01) 15974
    CrossrefPubMedGoogle Scholar
  • 75 Mukai N, Nakayama Y, Ishi S. , et al. Changes in microRNA expression level of circulating platelets contribute to platelet defect after cardiopulmonary bypass. Crit Care Med 2018; 46 (08) e761-e767
    CrossrefPubMedGoogle Scholar
  • 76 Mair J, Lindahl B, Hammarsten O. , et al. How is cardiac troponin released from injured myocardium?. Eur Heart J Acute Cardiovasc Care 2018; 7 (06) 553-560
    CrossrefPubMedGoogle Scholar
  • 77 Mair J, Lindahl B, Müller C. , et al. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care 2018; 7 (06) 577-586
    CrossrefPubMedGoogle Scholar
  • 78 Vafaie M, Slagman A, Möckel M. , et al. Prognostic value of undetectable hs Troponin T in suspected acute coronary syndrome. Am J Med 2016; 129 (03) 274-282
    CrossrefPubMedGoogle Scholar
  • 79 Devaux Y, Mueller M, Haaf P. , et al. Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J Intern Med 2015; 277 (02) 260-271
    CrossrefPubMedGoogle Scholar
  • 80 Zeller T, Keller T, Ojeda F. , et al. Assessment of microRNAs in patients with unstable angina pectoris. Eur Heart J 2014; 35 (31) 2106-2114
    CrossrefPubMedGoogle Scholar
  • 81 Karakas M, Schulte C, Appelbaum S. , et al. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur Heart J 2017; 38 (07) 516-523
    PubMedGoogle Scholar
  • 82 Schulte C, Molz S, Appelbaum S. , et al. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One 2015; 10 (12) e0145930
    CrossrefPubMedGoogle Scholar
  • 83 Yu XY, Chen JY, Zheng ZW. , et al. Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention. EuroIntervention 2013; 9 (05) 546-554
    CrossrefPubMedGoogle Scholar
  • 84 Jansen F, Yang X, Proebsting S. , et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc 2014; 3 (06) e001249
    PubMedGoogle Scholar
  • 85 Jakob P, Kacprowski T, Briand-Schumacher S. , et al. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction. Eur Heart J 2017; 38 (07) 511-515
    PubMedGoogle Scholar
  • 86 Han M, Yang Z, Sayed D. , et al. GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res 2012; 93 (04) 645-654
    CrossrefPubMedGoogle Scholar
  • 87 Emmrich S, Henke K, Hegermann J, Ochs M, Reinhardt D, Klusmann JH. miRNAs can increase the efficiency of ex vivo platelet generation. Ann Hematol 2012; 91 (11) 1673-1684
    CrossrefPubMedGoogle Scholar
  • 88 Ren XP, Wu J, Wang X. , et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009; 119 (17) 2357-2366
    CrossrefPubMedGoogle Scholar
  • 89 Zampetaki A, Willeit P, Tilling L. , et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012; 60 (04) 290-299
    CrossrefPubMedGoogle Scholar
  • 90 Badrnya S, Baumgartner R, Assinger A. Smoking alters circulating plasma microvesicle pattern and microRNA signatures. Thromb Haemost 2014; 112 (01) 128-136
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 91 Bye A, Røsjø H, Nauman J. , et al. Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - The HUNT study. J Mol Cell Cardiol 2016; 97: 162-168
    CrossrefPubMedGoogle Scholar
  • 92 Häntzsch M, Tolios A, Beutner F. , et al. Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and MiRNA profiles. PLoS One 2014; 9 (12) e113298
    CrossrefPubMedGoogle Scholar
  • 93 Boeckel JN, Thomé CE, Leistner D, Zeiher AM, Fichtlscherer S, Dimmeler S. Heparin selectively affects the quantification of microRNAs in human blood samples. Clin Chem 2013; 59 (07) 1125-1127
    CrossrefPubMedGoogle Scholar
  • 94 Kaudewitz D, Lee R, Willeit P. , et al. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost 2013; 110 (03) 609-615
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 95 Zampetaki A, Mayr M. Analytical challenges and technical limitations in assessing circulating miRNAs. Thromb Haemost 2012; 108 (04) 592-598
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 96 Ach RA, Wang H, Curry B. Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. BMC Biotechnol 2008; 8: 69
    CrossrefPubMedGoogle Scholar
  • 97 Gidlöf O, Andersson P, van der Pals J, Götberg M, Erlinge D. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 2011; 118 (04) 217-226
    CrossrefPubMedGoogle Scholar
  • 98 Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-179
    CrossrefPubMedGoogle Scholar
  • 99 Willeit P, Skroblin P, Moschen AR. , et al. Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes. Diabetes 2017; 66 (02) 347-357
    CrossrefPubMedGoogle Scholar
  • 100 Li J, Chen H, Ren J. , et al. Effects of statin on circulating microRNAome and predicted function regulatory network in patients with unstable angina. BMC Med Genomics 2015; 8: 12
    CrossrefPubMedGoogle Scholar
  • 101 Weber M, Baker MB, Patel RS, Quyyumi AA, Bao G, Searles CD. MicroRNA expression profile in CAD patients and the impact of ACEI/ARB. Cardiol Res Pract 2011; 2011: 532915
    PubMedGoogle Scholar